Key result
A 20-year-old woman with systemic sclerosis developed arrhythmogenic right ventricular cardiomyopathy characterized by massive myocardial atrophy and fibro-fatty replacement, leading to sudden cardiac death.
Case Report (n=1)
No
This case highlights that primary and isolated right ventricular myocardial involvement, including ARVC, can occur in patients with systemic sclerosis and may lead to sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible isolated RV involvement in systemic sclerosis; leaves open whether targeted screening improves outcomes.
A 20-year-old Japanese woman with systemic sclerosis was evaluated for the progressive aggravation of chest pain, palpitations and dyspnea. Cardiac magnetic resonance imaging revealed diffuse wall thinning, segmental dyskinesis and late gadolinium enhancement of the right ventricular (RV) myocardium. Cardiac catheterization demonstrated no pulmonary hypertension. 24-hour electrocardiography monitoring showed non-sustained ventricular tachycardia (VT). Pulseless VT was induced via programmed ventricular stimulation. An endomyocardial biopsy of the right side of the interventricular septum was performed, the histological specimen of which demonstrated massive myocardial atrophy and fibro-fatty replacement with predominant fibrotic changes. The patient was ultimately diagnosed with arrhythmogenic RV cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Dohi et al. (2014) conducted a case report in Systemic Sclerosis and Arrhythmogenic Right Ventricular Cardiomyopathy (n=1). Systemic Sclerosis was evaluated. A 20-year-old woman with systemic sclerosis developed arrhythmogenic right ventricular cardiomyopathy characterized by massive myocardial atrophy and fibro-fatty replacement, leading to sudden cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: